Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Yajnik

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|January 21, 2017
The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseasesG Conway, G Velonias, E Andrews, et al.
Oncogene|July 22, 2008
Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signalingG Upadhyay, W Goessling, T E North, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2016
Genetic basis of TNF-α antagonist associated psoriasis in inflammatory bowel diseases: a genotype-phenotype analysisP Vedak, D Kroshinsky, J St John, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2015
Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysisV Gupta, R Rodrigues, D Nguyen, et al.
Oncogene|April 20, 1995
The cloning of Grb10 reveals a new family of SH2 domain proteinsJ Ooi, V Yajnik, D Immanuel, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Genetic risk factors for Clostridium difficile infection in ulcerative colitisA N Ananthakrishnan, E C Oxford, D D Nguyen, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2012
Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel diseaseP S A de Silva, D D Nguyen, J Sauk, et al.
The Journal of the Association of Physicians of India|February 1, 1994
Ramipril vs captopril in mild to moderate hypertensionV H Yajnik, D J Vatsraj, H K Acharya, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2015
New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel diseaseE Shelton, K Chaudrey, J Sauk, et al.
Nature|May 6, 1993
Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signallingN Li, A Batzer, R Daly, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|January 21, 2017
The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseasesG Conway, G Velonias, E Andrews, et al.
Oncogene|July 22, 2008
Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signalingG Upadhyay, W Goessling, T E North, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2016
Genetic basis of TNF-α antagonist associated psoriasis in inflammatory bowel diseases: a genotype-phenotype analysisP Vedak, D Kroshinsky, J St John, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2015
Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysisV Gupta, R Rodrigues, D Nguyen, et al.
Oncogene|April 20, 1995
The cloning of Grb10 reveals a new family of SH2 domain proteinsJ Ooi, V Yajnik, D Immanuel, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Genetic risk factors for Clostridium difficile infection in ulcerative colitisA N Ananthakrishnan, E C Oxford, D D Nguyen, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2012
Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel diseaseP S A de Silva, D D Nguyen, J Sauk, et al.
The Journal of the Association of Physicians of India|February 1, 1994
Ramipril vs captopril in mild to moderate hypertensionV H Yajnik, D J Vatsraj, H K Acharya, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2015
New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel diseaseE Shelton, K Chaudrey, J Sauk, et al.
Nature|May 6, 1993
Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signallingN Li, A Batzer, R Daly, et al.
Pageof 3